Can you imagine people on here if we missed out on a decent slice of 6 BILLION?!?
Is Immunization/Vaccines part of the reason we where cash flow positive last quarter as well?
Strong cash flow generation in quarter driven by R&D refund of $1.5M relating to Admedus Vaccines and unwinding of working capital investments made in H1.
Just a thought.
Coads
Tissue Engineering v. Immunotherapy, page-18
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.20 |
Change
0.200(1.11%) |
Mkt cap ! $349.8M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.20 | $17.65 | $78.15K | 4.366K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 619 | $17.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.20 | 146 | 1 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |